Literature DB >> 1093647

Prophylactic chemotherapy with low-dosage trimethoprim-sulfamethoxazole following acute urinary tract infections in children.

N Sher.   

Abstract

The cases of 10 children with acute and recurrent infection of the urinary tract are presented. Their ages were between 7 weeks and 9 years. Five of the children had been previously treated with a combination of sulfisoxazole, ampicillin, mandelamine and nitrofurantion and four of these children had "breakthrough" infections. When trimethoprim-sulfamethoxazole was administered twice weekly no further infections were noted in four of these five patients. The second group of five children were started on trimethoprim-sulfamethoxazole from the start of their infection and treatment was continued twice weekly for 5 to 7 months. No recurrence of infection of the urine has been detected up to the present time. It is concluded that treatment with trimethoprim-sulfamethoxazole initiated at the outset of urinary tract infection and twice weekly is a valuable drug in children, provided the organism responsible for the infection is sensitive to this agent.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1093647      PMCID: PMC1956461     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  PROGNOSIS OF CHILDHOOD URINARY-TRACT INFECTION. THE CURRENT STATUS OF PATIENTS HOSPITALIZED BETWEEN 1940 AND 1950.

Authors:  R E STEELE; G W LEADBETTER; J D CRAWFORD
Journal:  N Engl J Med       Date:  1963-10-24       Impact factor: 91.245

2.  Trimethoprim-sulfamethoxazole in recurrent urinary tract infection in children.

Authors:  P A Forbes; K N Drummond
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

  2 in total
  2 in total

Review 1.  Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review.

Authors:  N Le Saux; B Pham; D Moher
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

Review 2.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.